BioCardia Biotherapeutic Delivery and Morph Access Innovations Business Development Update for Shareholders
January 03, 2024 07:00 ET
|
BioCardia, Inc.
SUNNYVALE, Calif., Jan. 03, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. (Nasdaq: BCDA), a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases,...
BioCardia Issued New U.S. Patent for Technology that Enhances Control for Interventional Catheter Based Therapies
October 12, 2021 08:00 ET
|
BioCardia, Inc.
SAN CARLOS, Calif., Oct. 12, 2021 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA] a company focused on developing cellular and cell-derived therapeutics for the treatment of cardiovascular and...